HPTN 084 (LIFE) is a research study that compares the effectiveness of injections and oral tablets as pre-exposure prophylaxis (PrEP) to prevent HIV in women.
HPTN 084 will enroll participants in 20 sites in 7 countries in sub-Saharan Africa: Botswana, Eswatini, Kenya, Malawi, South Africa, Uganda and Zimbabwe.
See site contact information here.
The HPTN
